Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by Surgery
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kimmie Ng
Academic and Community Cancer Research United
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic in Arizona
Scottsdale, Arizona, United States
- Saint Luke'S Mountain States Tumor Institute
Boise, Idaho, United States
- Siouxland Regional Cancer Center
Sioux City, Iowa, United States
- Cancer Center of Kansas - Wichita
Wichita, Kansas, United States
- Ochsner Medical Center Jefferson
New Orleans, Louisiana, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Michigan Cancer Research Consortium Ncorp
Ann Arbor, Michigan, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Heartland Regional Medical Center
Saint Joseph, Missouri, United States
- Missouri Baptist Medical Center
St Louis, Missouri, United States
- New Hampshire Oncology Hematology Pa-Hooksett
Hooksett, New Hampshire, United States
- State University of New York Upstate Medical University
Syracuse, New York, United States
- Saint Vincent Regional Cancer Center Ccop
Green Bay, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 Dec 2014
- Primary completion
- 20 Mar 2019
- Completion
- 27 Sept 2019
- Last update posted
- 31 Jan 2022
- Registered enrollment
- 36
- Registry id
- NCT02292758
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.